Total Credits: .75 including .75 AOA Category 1-A Credit(s), .75 AMA PRA Category 1 Credit(s)™
Management of pancreatic cancers has changed significantly over the past few years. Targeted and immune-modulated therapies have changed the face of the disease.
• Recognize common complaints and symptoms in a patient with pancreatic carcinoma.
• Outline a process of evaluation of a patient with suspected adenocarcinoma of the pancreas.
• Discuss current treatment options and management strategies in pancreatic adenocarcinoma.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of .75 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this live activity for a maximum of .75 AMA PRA Category 1 Creditä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The MAOPS Education Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
PP - Pancreatic Cancer - New Treatment Options 2020
|48 Pages||Available after Purchase|
Dr. Kevin Hubbard is currently a hospice and palliative care physician with Saint Luke’s Health System in Kansas City, Missouri. Prior to his current position, he served as professor and Internal Medicine chair at Kansas City University of Medicine and Biosciences - College of Osteopathic Medicine (KCU-COM). He serves as Associate Medical Director for Saint Luke’s Hospice. Dr. Hubbard serves in leadership and advisory capacities in many osteopathic professional organizations. He served as President of the American College of Osteopathic Internists (ACOI) from 2007 to 2008 and was recognized by the ACOI as “Internist of the Year” in 2013. He also served as MAOPS President in 2011. MAOPS presented Dr. Hubbard with the “Physician of the Year” and Distinguished Service awards for his many years of dedication and outstanding service to the association and profession.
Dr. Hubbard is a third-generation graduate of KCU-COM and completed residencies in Internal Medicine at KCU-COM (when it was under the name of the University of Health Sciences in Kansas City) and in Internal Medicine at Normandy Osteopathic Hospital in St. Louis. He completed a fellowship in Medical Oncology and Hematology at the University of Texas, MD Anderson Cancer Center in Houston, Texas. Dr. Hubbard is board certified in Internal Medicine, Medical Oncology, Hematology, and Hospice/Palliative Medicine by the American Osteopathic Board of Internal Medicine. He is also board certified as a Hospice Medical Director by the Hospice Medical Director Certification Board.
Dr. Hubbard discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients relative to the content of his presentation.
Please wait ...